Abstract: Aqueous solubility and permeability through biomembranes are important parameters for drug bioavailability. Nanoparticles can be considered as a useful tool for improving properties of poorly soluble and/or permeable active ingredients. Hydrochlorothiazide (Class IV of BCS) was chosen as a model compound. Antisolvent precipitation -solvent evaporation and emulsion solvent evaporation methods were used as techniques for preparation of twelve samples containing hydrochlorothiazide nanoparticles. Water solutions of the surfactants sodium dodecyl sulfate and Tween 80 were used in mass concentrations of 1, 3 and 5%. Acetone and dichloromethane were used as solvents of model compound. The particle size of the prepared samples was measured by dynamic light scattering. The particle size ranged from 4.2 to 102.2 nm. Tween 80, that yielded nanoparticles <15 nm, was a preferable excipient to sodium dodecyl sulfate.
INTRODUCTION

Hydrochlorothiazide
( Figure  1 ), 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, is a thiazide diuretic that is frequently used in antihypertensive therapy in combination with antihypertensive agents. Hydrochlorothiazide affects the distal renal tubular mechanism of electrolyte reabsorption: it increases excretion of sodium and chloride ions [1] . Due to this increased excretion, it increases diuresis. Hydrochlorothiazide is not a first choice drug for hypertension treatment at patients with diabetes mellitus because of metabolic side effects. Hydrochlorothiazide can cause hyperglycaemia, it can worsen glucose tolerance and cause hypercholesterolemia [2] . There is a question if hydrochlorothiazide nanoparticles would have less adverse effects in a range of metabolic side effects. Hydrochlorothiazide belongs to Class IV of the Biopharmaceutical Classification System (BCS). Drugs of the mentioned class are characterized by poor water solubility and low permeability; it means they are problematic from the point of view of oral bioavailability [3] . Some nanonized drug substances, such as megestrole acetate (Megace ® ), methylphenidate (Ritalin ® ), aprepitant (Emend ® ), sirolimus (Rapamune ® ) [4] and nanonized fenofibrate [5] , have been used in human treatment. Doses of nanodrugs can be lower than doses of bulk drugs, which results in lower metabolic load and lower incidence of side effects [4] . The aim of this study was to investigate what surfactant is more convenient for preparation of stabilized hydrochlorothiazide nanoparticles via antisolvent precipitation with the following solubility and permeability experiments. It can be supposed that hydrochlorothiazide nanoparticles would have improved bioavailability. There are two main approaches of nanoparticles preparation: bottom-up and top-down. Top-down techniques are based on milling or high-pressure homogenization. The bottom-up approach is mainly based on precipitation [4, [6] [7] [8] . This approach was used in this study. Polar and nonpolar solvents were used in this investigation; therefore, the exact principle of the applied solvent evaporation method is dependent on the water-based system, including or not an aqueous miscible organic solvent. Polar acetone and nonpolar dichloromethane were chosen as the most suitable solvents for easy dissolution of hydrochlorothiazide; so two different possible mechanisms were used for the nanoparticle synthesis. When hydrochlorothiazide is dissolved in acetone and then mixed with water containing a stabilizer, nanoparticles are formed spontaneously and immediately upon mixing. This method can be called antisolvent precipitation -solvent evaporation, and the procedure is in principle similar to the evaporative precipitation into aqueous solution [9, 10] and the liquid antisolvent precipitation [11] . When hydrochlorothiazide is dissolved in dichloromethane and then mixed with water containing stabilizers, an emulsion (o/w type) is formed; hydrochlorothiazide is clustered by the excipient, which results in the encapsulation of hydrochlorothiazide into nano-vesicula. This combination of emulsification and solvent evaporation in nanoparticle synthesis is called emulsion solvent evaporation [12, 13] . 
RESULTS AND DISCUSSION
Based on the pilot screening [14, 15] , excipients such as sodium dodecyl sulfate (Series 1, 2) and Tween 80 (Series 3, 4) were chosen from the group of surfactants. Three water solutions of 1%, 3% and 5% mass concentration were prepared. Hydrochlorothiazide was solved in dichloromethane (Series 1, 3) as a non-polar solvent and acetone (Series 2, 4) as a polar solvent. Drug solution was added to the solution of excipient under continuous stirring. Organic solvent was evaporated in an ultrasonic bath that was used as a source of complementary energy for nanoparticles preparation. The combination of all excipients with hydrochlorothiazide provided twelve samples, see Table 1 . All prepared samples were measured by dynamic light scattering [16] , i.e., the particle size and values of polydispersity index were determined (see Table 1 ). The suitability of the used surfactant and the organic solvent was analysed. The investigated particles showed good particle size stability throughout the light scattering measurements, except for sample 3c that could not be measured due to crystallization of hydrochlorothiazide. In the period of measurements, no significant deviations from the mean values of particle size, which could be a result of possible sample ageing, were observed. Also a regular visual check of the samples proved no changes in the sample structure, which was confirmed by the reproducible data obtained by the light scattering method. Nanoparticles of size ca. 100 nm were prepared only in the case of sodium dodecyl sulfate in 3% concentration (sample 1b) in combination with dichloromethane. Sodium dodecyl sulfate in combination with dichloromethane provided particle size near 20 nm (samples 1a and 1c). Other prepared samples contained nanoparticles in the size range from 4.2 to 13.6 nm, mostly near 10 nm. These observations are shown in detail in Figures 2 and 3 , where the dependences of particle size [nm] expressed as mean ± SD of hydrochlorothiazide dissolved in dichloromethane or acetone on the concentration [%] of sodium dodecyl sulfate (Fig. 2) and Tween (Fig. 3) in water are illustrated. The dispersity is a measure/degree of the homogeneity/heterogeneity of sizes of particles in a mixture/system. The uniformity of dispersed systems is expressed as polydispersity index (PDI), see Table 1 . Low PDI values demonstrate narrow size distribution and uniformity of samples contrary to PDI ≈ 1 that indicates that samples have a very broad size distribution, may contain large particles or aggregates and are not suitable for measurements [17, 18] . In the prepared nanoparticles of hydrochlorothiazide PDI values ranged from 0.128 to 0.302, when the samples 1a-c (with PDI values ranging 0.356-0.654) were eliminated. It is evident that the combination of sodium dodecyl sulfate and dichloromethane was suitable at least within this study and the series of samples either for generation of samples with a larger size or for higher degree of heterogeneity. The results showed that acetone is a preferable solvent for generation of hydrochlorothiazide nanoparticles of a smaller size.
Nanoparticles prepared with acetone also featured little variation in the particle size. The combinations of Tween 80 in all the concentrations, except for 5% Tween 80 with dichloromethane that precipitated, provided a smaller particle size (<15 nm). On the other hand, nanoparticles stabilised with sodium dodecyl sulfate were more stable. No precipitation occurred after the preparation. 
EXPERIMENTAL
General Procedure for Preparation of Nanoparticles
The model compound hydrochlorothiazide and the excipients sodium dodecyl sulfate and Tween 80 were purchased from Sigma-Aldrich (Germany). All compounds were of analytical grade. H 2 O-HPLC -Mili-Q Grade was used as a solvent of excipients. Each excipient (0.1 g, 0.3 g or 0.5 g) was dissolved in water (10 mL), and three solutions with mass concentrations 1%, 3% and 5% were prepared. Hydrochlorothiazide (0.1 g) was dissolved in dichloromethane or acetone (10 mL), i.e. 1% solutions were prepared. The solution of hydrochlorothiazide in dichloromethane/acetone was slowly dropped (2 mL/min) to the aqueous solutions of excipients, and the solutions were stirred at 600 rpm for 15 minutes at 25 °C, after which the mixtures were transferred to the ultrasonic bath in the fume chamber, where they were mixed again for 20 minutes for homogenization of the samples. Finally, the solvent was evaporated.
Dynamic Light Scattering Measurements
The particle size was determined using a Brookhaven dynamic light scattering system BI 9000 (Brookhaven Instruments Corporation, Holtsville, NY, USA) with a goniometer SM-200 and an argon gas laser (Lexel 95, wavelength 514.5 nm). Scattered intensity was registered at the scattering angle 90° and the temperature of 25 °C. All the samples were dispersed by sonication and additionally filtered directly before the measurement through syringe filters with 0.45 μm pore size to remove mechanical impurities. Five independent recordings of the autocorrelation function were done for each investigated excipient concentration. The particle size was calculated from the translational diffusion coefficient using the Stokes-Einstein formula. The translational diffusion coefficient was obtained based on the cumulant expansion of the autocorrelation function up to the second cumulant. The presented particle sizes are reported as the mean values taken of the set of five independent measurements. The results are summarized in Table 1 and illustrated in Figures 2 and 3 .
